Cargando…
Biochemical aspects of dementias
Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, and prion diseases are age-related neurodegenerative disorders associated with a progressive decline of cognitive brain functions. Due to the increase in prevalence rates, and the rising costs associated with clinical and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181716/ https://www.ncbi.nlm.nih.gov/pubmed/22034215 |
_version_ | 1782212796213100544 |
---|---|
author | Hock, Christoph |
author_facet | Hock, Christoph |
author_sort | Hock, Christoph |
collection | PubMed |
description | Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, and prion diseases are age-related neurodegenerative disorders associated with a progressive decline of cognitive brain functions. Due to the increase in prevalence rates, and the rising costs associated with clinical and social care, treatments designed to prevent or reverse these diseases are urgently needed. The most common major biochemical characteristic of these neurodegenerative diseases is the deposition of abnormal protein aggregates in brain. The decryption of the mechanisms of aggregation and associated neurotoxicity may reveal new therapeutic targets, which will enable treatment for these devastating conditions. |
format | Online Article Text |
id | pubmed-3181716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-31817162011-10-27 Biochemical aspects of dementias Hock, Christoph Dialogues Clin Neurosci Basic Research Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, and prion diseases are age-related neurodegenerative disorders associated with a progressive decline of cognitive brain functions. Due to the increase in prevalence rates, and the rising costs associated with clinical and social care, treatments designed to prevent or reverse these diseases are urgently needed. The most common major biochemical characteristic of these neurodegenerative diseases is the deposition of abnormal protein aggregates in brain. The decryption of the mechanisms of aggregation and associated neurotoxicity may reveal new therapeutic targets, which will enable treatment for these devastating conditions. Les Laboratoires Servier 2003-03 /pmc/articles/PMC3181716/ /pubmed/22034215 Text en Copyright: © 2003 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Basic Research Hock, Christoph Biochemical aspects of dementias |
title | Biochemical aspects of dementias |
title_full | Biochemical aspects of dementias |
title_fullStr | Biochemical aspects of dementias |
title_full_unstemmed | Biochemical aspects of dementias |
title_short | Biochemical aspects of dementias |
title_sort | biochemical aspects of dementias |
topic | Basic Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181716/ https://www.ncbi.nlm.nih.gov/pubmed/22034215 |
work_keys_str_mv | AT hockchristoph biochemicalaspectsofdementias |